Madeline Brown explores the horrifying practice of fertility fraud and its effects, alongside legislative efforts to protect victims and hold perpetrators accountable. Specifically, this article evaluates the strengths and weaknesses of two federal bills: the Protecting Families from Fertility Fraud Act and the Fighting Fertility Fraud Act.
Emotional Support Animal Certification: It Is Time to Stop Psyching Out Our Healthcare Providers
Emotional support animals have grown in popularity in recent years, but sparse regulations on emotional support animal certification have left both healthcare providers and patients in a difficult spot. In this article, Associate Member Adam Drapcho argues for more structured guidance for emotional support animal certification.
Patent Evergreening and the Response by the USPTO and FDA
In her most recent blog post, Associate Member Emmaline Fisher discusses patent evergreening, its effects on prescription drug prices, and the USPTO’s and the FDA’s response to President Biden’s Executive Order that this issue be addressed and fixed.
Capping the Flood: Efforts to Address the Ever-Rising Price of Insulin
In this article, Associate Member Emmaline Fisher discusses the limitations of the insulin cap passed with the Inflation Reduction Act, and some currently pending legislation in Congress that seeks to address the ever-increasing cost of insulin.
PrEPare to be Overturned: Why U.S. Courts Must Scrutinize Religious Freedom Claims More Closely
Associate Member Chris Colloton examines the recent decision from a federal court in Texas in Braidwood Management, Inc. v. Becerra. Chris argues that the judge not only misapplied the law, but moreover worked to elevate religious freedom to an untenable level at the expense of the health of millions of Americans.